antipyrine/benzocaine otic (Auralgan, Auroto)

From Aaushi
Jump to navigation Jump to search

Introduction

Benzocaine 1.4%, antipyrine 5.4% in glycerin*

Indications

Contraindications

sensitivity to ester-type local anesthetics

Dosage

Adverse effects

(< 1%)

Mechanism of action

* New formulation substitutes acetic acid & U-polycosanol 410 for glycerin; price increases from $2 to $150[4]

More general terms

References

  1. The Pharmacological Basis of Therapeutics, 9th ed. Gilman et al, eds. Permagon Press/McGraw Hill, 1996
  2. Drug Information & Medication Formulary, Veterans Affairs, Central California Health Care System, 1st ed., Ravnan et al eds, 1998
  3. Kaiser Permanente Northern California Regional Drug Formulary, 1998
  4. 4.0 4.1 Prescriber's Letter 15(5): 2008 The New Auralgan Formulation Detail-Document#: http://prescribersletter.com/(5bhgn1a4ni4cyp2tvybwfh55)/pl/ArticleDD.aspx?li=1&st=1&cs=&s=PRL&pt=3&fpt=25&dd=240502&pb=PRL (subscription needed) http://www.prescribersletter.com

Database